The best indicator for Regeneron Pharmaceuticals (REGN)
We backtested 366 indicators across daily, weekly and hourly charts on real Regeneron Pharmaceuticals (REGN) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Ultimate Oscillator
On the daily chart, this is the strongest risk-adjusted edge we found for Regeneron Pharmaceuticals (REGN) over ~35.2 years — beating buy-and-hold by 7.3% CAGR.
Best multi-indicator combo
Going long only when all 3 agree was the strongest confluence setup we found for Regeneron Pharmaceuticals (REGN) — trailing buy-and-hold by 5.0% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Ultimate Oscillator ✓ | Daily | 17.5% | 0.57 | -82.6% | 76.9% | 39 | 7.3% |
| 2 | Heikin-Ashi Trend | Weekly | 15.0% | 0.51 | -60.9% | 43.4% | 327 | 4.3% |
| 3 | Ehlers Relative Vigor ✓ | Daily | 12.9% | 0.48 | -78.9% | 43.2% | 759 | 2.7% |
| 4 | Murrey Math Lines ✓ | Weekly | 12.4% | 0.48 | -63.1% | 78.9% | 19 | 1.7% |
| 5 | Intraday Momentum Index ✓ | Weekly | 11.4% | 0.47 | -69.4% | 65.0% | 20 | 0.7% |
| 6 | Stochastic | Daily | 11.2% | 0.46 | -76.1% | 69.9% | 156 | 1.0% |
| 7 | McGinley 100 Trend ✓ | Daily | 10.7% | 0.46 | -91.3% | 30.6% | 36 | 0.5% |
| 8 | Stochastic (20,5) | Daily | 11.8% | 0.46 | -86.9% | 43.0% | 646 | 1.6% |
| 9 | HMA 9/21 Cross ✓ | Weekly | 12.0% | 0.46 | -73.9% | 50.4% | 117 | 1.3% |
| 10 | Bollinger Mean-Reversion | Daily | 9.8% | 0.45 | -60.8% | 68.7% | 150 | -0.4% |
| 11 | Holy Grail Confluence | Daily | 10.2% | 0.45 | -66.5% | 75.0% | 60 | 0.0% |
| 12 | Fisher Transform ✓ | Daily | 11.2% | 0.45 | -89.9% | 43.3% | 843 | 1.0% |
| 13 | Keltner Mean-Reversion | Daily | 8.7% | 0.45 | -55.3% | 64.9% | 94 | -1.5% |
| 14 | Stochastic Slow (21,5) | Daily | 11.3% | 0.45 | -86.8% | 43.3% | 646 | 1.1% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Regeneron Pharmaceuticals (REGN), Ultimate Oscillator on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.